Vertebral hemangioma is usually a benign and asymptomatic tumor of blood vessels, but can be aggressive (symptomatic) with expansion, pain, and spinal cord compression. The aim of this study was to review the effects of radiotherapy, surgery, and other treatment approaches in patients with aggressive vertebral hemangioma.
Background
Vertebral hemangioma is a rare, benign vascular tumor of the vertebral body that is usually asymptomatic, but which can behave in a locally aggressive way by involving bone and local spread into the vertebral canal to cause spinal cord compression. Between 0.9-1.2% of vertebral hemangiomas are aggressive, or symptomatic [1] [2] [3] [4] [5] [6] , with aggressive vertebral hemangioma extending into the spinal canal and/or paravertebral space, leading to neurological deficit [2, 4, [7] [8] [9] [10] [11] [12] . The choice of treatment for aggressive vertebral hemangioma is controversial, and in the literature, most previous reports have focussed on surgical management [2, 4, 7, 8, [11] [12] [13] [14] .
Few previous studies have investigated the effectiveness of radiotherapy in the treatment of aggressive vertebral hemangioma, and the outcome of radiation treatment [6, [15] [16] [17] [18] [19] [20] [21] [22] [23] . There is also controversy regarding whether radiation therapy can induce malignant transformation in benign vertebral hemangioma [24, 25] .
In our clinical practice, radiotherapy is usually the first choice in patients with aggressive vertebral hemangioma who have mild or slowly developing neurological deficit. The aim of this retrospective study was to review the effects of radiotherapy, surgery, and other treatment approaches in patients with aggressive vertebral hemangioma.
Material and Methods Patients
Sixty-one patients underwent treatment in the Orthopedic Department of our hospital from 2001 to 2016 for aggressive vertebral hemangioma, including 20 patients who underwent radiotherapy as their first-line treatment in our hospital. Patients with surgery as the first-line treatment have been previously described, and most of the patients treated before 2001 were lost during follow-up because of frequent changes to their contact details. This study was approved by the local Ethics Committee of our hospital, and the study was conducted according to the principles of the Declaration of Helsinki. Because this was a retrospective study, informed consent was waived.
Patient data
Patient data were acquired from office charts, pathology reports, and radiology reports. The clinical and demographic data collected included age, sex, symptoms, radiological features before and after treatment, radiotherapy treatment and results, surgical records, and treatment complications. Neurological function was assessed by the modified Frankel Scale. Pain was evaluated for each patient using a visual analog scale (VAS). The inclusion criteria were that radiotherapy was the initial treatment and the minimal follow-up was 18 months.
Imaging and biopsy
Radiological studies included posteroanterior and lateral spinal radiography, computed tomography (CT), and magnetic resonance imaging (MRI). Typical lesions of vertebral hemangioma had vertical trabeculation and a honeycomb appearance on CT and a 'salt and pepper' appearance on MRI (Figure 1 ). In cases with atypical images, CT-guided biopsy was indicated and performed by local interventional radiologists. The ratios of the vertebral canal encroachment of the aggressive vertebral hemangioma lesions were measured on the median sagittal plane on the MRI (Figure 2 ).
Treatment protocol for aggressive vertebral hemangioma
Radiotherapy was prioritized when aggressive vertebral hemangiomas were accompanied by mild or slowly developing neurological deficit (muscle strength grade greater than 3/5). Lesions with bony destruction were evaluated using the spine instability (SIN) scores [26] , as either stable, suspected unstable requiring orthoses, or unstable requiring vertebroplasty or surgery. The benefits and risks of radiotherapy were discussed with the patients, and surgical treatment was provided as an alternative. For adolescent patients, the long-term risks of radiotherapy were discussed with the patients and their parents. Surgery was usually indicated for patients with severe or rapidly developing neurological deficits (muscle strength grade less than 3/5).
Radiotherapy was performed by local radiotherapy oncology specialists. The external radiation was divided into 20-25 fractions with a total dose of 40-50 Gy. Before 2012, three-dimensional conformal radiotherapy (3D-CRT) was used for the radiotherapy. Image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) were used after 2012. The radiotherapy was delivered to each patient as an outpatient. During radiotherapy, steroids and mannitol were available for use, in case there was worsening of neurological deficit after the radiotherapy.
Surgical decompression was indicated if the neurological deficit worsened during or after radiotherapy, or neurological symptoms were not relieved at two-months follow-up. If radiology revealed no re-ossification after radiotherapy, percutaneous vertebroplasty was available, if indicated, to prevent vertebral fractures.
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Clinical follow-up X-ray images of the vertebra were obtained at three, six, and 12 months after the index procedure and then annually after that. MRI and CT were performed at the three-month followup and repeated annually. VAS and neurological recovery were recorded. If the patient had recurrent symptoms, immediate MRI and CT scans were performed. The minimum follow-up duration was 18 months.
Review of the literature: Search strategy
A brief review of the literature was performed of the current management of aggressive vertebral hemangioma in the PubMed, EBSCO, OVID, and Springer databases. The search criteria included publications within the last 20 years, using the following search terms: aggressive spinal or vertebral hemangioma, radiotherapy, radiosurgery, and associated treatment. Cases were selected based on a specific diagnosis of aggressive 
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vertebral hemangioma, spinal cord compression, and neurological deficits with or without radiotherapy ( Tables 1, 2) .
Results

Patient information
The retrospective clinical review included 20 patients who underwent radiotherapy as their first-line treatment for symptomatic vertebral hemangioma with mild or slowly developing neurological deficit, and included eight men and 12 women. The age at diagnosis ranged from 16-72 years, with a mean age of 46.6 years. Of the 20 patients treated at our hospital, three patients had undergone surgical decompression at other hospitals, with recurrence of the hemangiomas. The aggressive vertebral hemangiomas were located in the cervical, thoracic, and lumbar vertebrae in four, 14, and two patients, respectively. Five patients had multiple vertebral hemangiomas with only a single aggressive lesion. All aggressive vertebral hemangiomas included epidural extension on magnetic resonance imaging (MRI).
The average duration of symptoms before presentation was 6.9 months (range, 1-17 months). Eighteen patients had Frankel D grade myelopathy, including five patients with local pain. The other two patients had Frankel E grade myelopathy with pain and radiculopathy. Two patients had a mild pathological vertebral fracture. All the spine lesions were stable or suspected unstable according to the spine instability (SIN) scores. Three illustrative cases out of the 20 cases in the study are presented in Figures 
Re-ossification after radiotherapy
Sixteen patients had vertebral destruction due to vertebral hemangioma and of these, only 37.5% (6/16) had significant re-ossification at an average of 68.3 months following radiotherapy ( Figure 5 ). Due to minor re-ossification, two of the 13 patients who were symptom-free after radiotherapy asked for percutaneous biopsy and vertebroplasty because they were concerned about the possibility of pathological fracture at 24 months and 60 months, respectively, following radiotherapy ( Figure 3 ). The histopathology results of the biopsies were negative for malignancy. Following vertebroplasty, these patients were symptom-free without recurrence at 60 months and 108 months follow-up, respectively.
Surgery after radiotherapy
Seven other patients required surgery after radiotherapy. Preoperative vascular embolization was not used in any patient in the study. Neurological deficit persisted in four patients and worsened in three patients, even after conservative treatment with mannitol and steroids (Table 3) . In these seven patients, neurological function was graded as Frankel D before radiotherapy and worsened to Frankel B and C after radiotherapy in one and two patients, respectively. Cervical spine lesions were present in one patient while six patients had thoracic spine lesions. All lesions involved the vertebral body and bilateral pedicles with epidural extension, including two cases with paravertebral involvements. The average duration between radiotherapy and surgery was 1.4 months (range, 1-2 months). Repeat MRI showed no progression of the tumor masses following radiotherapy.
The surgery performed was posterior decompression with laminectomy, including five intraoperative vertebroplasties ( Figure 4 ). Preoperative embolization was not mandatory. The postoperative pathological diagnosis remained that of benign hemangioma. The average surgery time was 245 min (range, 180-330 min). The average estimated blood loss was 801.4 mL (range, 260-2200 mL). At the last follow-up (average, 63.6 months; range, 20-120 months), six patients were symptom-free, and one patient still had mild symptoms (lower limb weakness) and was assigned a Frankel grade of D3. 
Vertebral canal encroachment of epidural hemangioma
For the 13 patients with successful radiotherapy, the average ratio of the vertebral canal encroachment was 27.5% (range, 4.0-39.4%) on MRI at diagnosis. The spinal cord compression consisted of a soft tumor mass in 10 patients with additional small, bony compression in three patients. In the three patients who experienced neurological deterioration after radiotherapy, the rates of vertebral canal encroachment were 67.7%, 53.8%, and 63.2% (mean 61.6%), respectively. Two compressions consisted of soft tumor mass and one of combined soft tissue and bone. Also, the four patients showing no neurological improvement after radiotherapy mainly had bony compression, including one patient with vertebral fracture before radiotherapy and kyphosis due to fracture. The rates of the vertebral canal invasion in the four patients were 43.2%, 43.7%, 47.9%, and 52.1% (mean, 46.7%) (Figure 4 ).
Discussion
The treatment for aggressive (symptomatic) vertebral body hemangioma, including radiotherapy, ethanol injections, surgical decompression, intralesional vertebrectomy and en-bloc . According to the literature, the primary treatment method for aggressive vertebral hemangioma is surgery, while radiotherapy is usually suggested as adjuvant treatment. Minimally invasive procedures have been reported to be successful only in small lesions [13] .
There have previously been few reports describing radiotherapy alone as the treatment of aggressive vertebral hemangioma, especially in cases with neurological deficit, and most of these previous publications were small case series or single case reports (Table 2 ) [15] [16] [17] [18] [19] [20] [21] [22] [23] . Hyde and coauthors [6] from seven major German institutions reviewed over 39 years of radiotherapy for 84 patients with symptomatic lesions of vertebral hemangioma, including 24 patients presenting with neurological symptoms, and showed an overall patient response rate of 90.5% after a median of 68 months of follow-up.
Although radiotherapy is usually safe and effective for aggressive vertebral hemangioma, it has some inherent drawbacks. First, the recovery of radiotherapy is relatively lower than that of surgery, which is reported to be almost 100%. In a report from Asthana et al. [15] , 6 out of 9 patients who suffered neurological deficits caused by vertebral hemangioma were completely 
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relieved of their symptoms (66.7%). In the 24 patients with vertebral hemangioma with neurologic symptoms, reported by Heyd et al. [6] , neurological symptoms were completely resolved in 79.2% of patients. In a retrospective study of 137 patients with vertebral hemangioma experiencing pain (neurological deficits were not mentioned), Miszczyk et al. reported that 78.4% showed relief 18 months after radiotherapy [5] .
Also, the recovery of neurological function is usually slow following treatment of vertebral hemangioma [10, 19] . In a study by Aich et al. [20] , radiotherapy was effective in six patients with vertebral hemangioma with neurological deficit. However, patients did not completely recover and their muscle strength took more than two years to improve. of five patients showed improvement during a mean period of one year [23] .
Finally, the condition of some patients may worsen following radiotherapy. To our knowledge, the present study is one of the few to discuss this particular outcome. The reason for slow or unsatisfactory neurological recovery might be explained by the morphological response of vertebral hemangioma following radiotherapy. In the five cases reported from Stanford University, even with CyberKnife stereotactic radiosurgery, two patients had only between 20-40% reduction in lesion size in the most responsive dimension, as noted on imaging [23] .
In the present study, seven out of the 20 cases experienced worse symptoms or did not experience symptom relief after radiotherapy. Patients experiencing severe neurologic
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A E D B F C compression (over 40%, especially with bony compression) most likely had unsatisfactory results after radiotherapy. The possible reason was assumed to be the edema associated with the vertebral hemangioma lesion after radiotherapy, which might lead to neurologic deterioration, potentially requiring surgical intervention.
Radiotherapy might partially repair bony destruction otherwise, secondary vertebral fracture is possible [22] . In the report by Heyd et al., the re-ossification rate was only 26.2% [6] . Miszczyk et al. reported that the re-ossification rate and/or fatty conversion rate was 33.3% [5] . Sakata et al. reported that there were no signs of re-ossification five years after radiotherapy in 14 cases of vertebral hemangioma [16] . In the present study, the re-ossification rate was 37.5%. In the report by Cloran et al., a single vertebral hemangioma case experienced pain and recurrence after radiotherapy because of a second vertebral fracture, which was corrected by percutaneous vertebroplasty [24] . In the present study, percutaneous vertebroplasty was provided for two patients.
This study had several limitations. This was a retrospective study that included a small number of patients from a single center. The evaluation of larger patient numbers and more detailed analysis of treatment approaches for patients with aggressive vertebral hemangioma is needed. Controlled, multicenter, large-scale clinical studies are required in future to provide the evidence base for the optimum treatment for patients with aggressive (symptomatic) vertebral hemangioma. 
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